Shingrix is the first new shingles vaccine in more than a decade and only the second to ever be approved (Zostavax was the first) by the Food and Drug Administration. In October the Advisory Committee on Immunization Practices, or ACIP, came out with three major recommendations for Shingrix, and the CDC officially accepted them.